Mr Mrs Miss Ms Dr Other

Dr
Ningning
Gao

Trainee Patent Attorney Assistant

London Office

Technology & Engineering

Telephone. +44(0) 207 776 5158
Email. ngao@hgf.com
Vcard

Experience

Before joining HGF, Ningning completed her Ph.D. at the University of Cambridge, where she conducted extensive research on the fabrication methods of III–V nanowire optoelectronic devices for solar energy harvesting, and developed novel techniques for producing flexible, ultra-thin, polymer-encapsulated devices.

Prior to this, she obtained a Master of Research in Connected Photonic and Electronic Systems from University College London, where her projects focused on the simulation and analysis of nanoscale hardware devices.

Her expertise spans semiconductor and nanotechnologies, as well as electronic and photonic systems applications in various fields.

While at Cambridge, she also worked part-time at Cancer Research UK, gaining valuable skills and insights into the healthcare industry.

Specialisms

Industries

Services

Qualifications

Trainee

BSC

Mathematics

MSC

Electrical Engineering. Specialising in connected photonic and electronic systems.

PHD

Electrical Engineering. Specialising in semiconductor nanofabrication.

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us